Literature DB >> 8918404

Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.

J M Bréchot1, S Chevret, M C Charpentier, C Appere de Vecchi, F Capron, J Prudent, J Rochemaure, C Chastang.   

Abstract

BACKGROUND: The objective of this prospective study was to assess in 96 patients with resected nonsmall cell lung carcinoma (NSCLC) the prevalence of both blood and lymphatic vessel invasion (BVI and LVI) according to stage, as well as their prognostic value for disease free and overall survival.
METHODS: BVI and LVI were evaluated by hematoxylin and eosin stains on surgical specimens after resection. Associations among variables were tested by Fisher's exact test or the chi-square test; prognostic values on time-failure data were analyzed by the log rank test and the multivariate Cox model.
RESULTS: BVI was present in 52% of NSCLC cases and LVI in 59%. Venous but not arterial vascular invasion correlated with the T factor and pTNM, whereas LVI correlated with the N factor and pTNM. In univariate analysis, LVI but not BVI was associated with a short disease free interval (P = 0.0007) and poor survival (P = 0.0001). The estimated relative risk of death in patients with LVI was 3.2 compared with patients without LVI. In multivariate analysis, LVI and pTNM were additional predictors for poor disease free and overall survival. In this series, BVI had no prognostic value.
CONCLUSIONS: The prevalence of BVI and LVI appeared high in patients with NSCLC, especially those with advanced pTNM stages. LVI was predictive of poor outcome, both time to recurrence and death.

Entities:  

Mesh:

Year:  1996        PMID: 8918404

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

Review 1.  [Diagnostic imaging of pulmonary lymphangiosis carcinomatosis].

Authors:  B Rehbock; H-G Hieckel
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

2.  Microfluidic perfusion culture system for multilayer artery tissue models.

Authors:  Yuka Yamagishi; Taisuke Masuda; Michiya Matsusaki; Mitsuru Akashi; Utako Yokoyama; Fumihito Arai
Journal:  Biomicrofluidics       Date:  2014-12-03       Impact factor: 2.800

3.  Prognostic value of the frequency of vascular invasion in stage I non-small cell lung cancer.

Authors:  Satoshi Okada; Shinjiro Mizuguchi; Nobuhiro Izumi; Hiroaki Komatsu; Michihito Toda; Kantaro Hara; Takahiro Okuno; Toshihiko Shibata; Hideki Wanibuchi; Noritoshi Nishiyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-10-13

4.  Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer.

Authors:  Jun Li; Mei Hong; Tiecheng Pan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Tumor-stroma ratio is an independent predictor for survival in NSCLC.

Authors:  Tiehong Zhang; Jun Xu; Hongchang Shen; Wei Dong; Yang Ni; Jiajun Du
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Jun Wang; Jianpeng Chen; Xi Chen; Baocheng Wang; Kainan Li; Jingwang Bi
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

7.  A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index.

Authors:  B Colinet; W Jacot; D Bertrand; S Lacombe; M-C Bozonnat; J-P Daurès; J-L Pujol
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

8.  Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.

Authors:  Jun Wang; Baocheng Wang; Weipeng Zhao; Yan Guo; Hong Chen; Huili Chu; Xiuju Liang; Jingwang Bi
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients.

Authors:  E Ogawa; K Takenaka; K Yanagihara; M Kurozumi; T Manabe; H Wada; F Tanaka
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

10.  Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment.

Authors:  C I M Baeten; J Wagstaff; I C L Verhoeven; H F P Hillen; A W Griffioen
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.